Catalyst
Slingshot members are tracking this event:
Lilly (LLY) and Boehringer Ingelheim's Glyxambi Recommended for Approval by European Ad Comm for Type 2 Diabetes
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| Boehringer Ingelheim |
|
|
LLY |
|
|
|
Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 16, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Glyxambi, European Medicines Agency, Chmp, Type 2 Diabetes
